Julie Sawyer Montgomery Assumes Role as Danaher President and Chief Executive Officer
Rainer Blair will remain a senior advisor until March 31, 2027 to support the leadership transition.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Danaher (DHR) announced Julie Sawyer Montgomery has assumed the roles of President and Chief Executive Officer, effective October 1, 2026. She also joined the Board of Directors, following the succession announcement on August 3, 2026. Rainer Blair will serve as a senior advisor until March 31, 2027 to support the transition.
Key Figures
- CEO appointment effective
- Oct. 1, 2026
- Montgomery assumed the President and CEO roles and joined the board
- Senior advisor term through
- March 31, 2027
- Rainer Blair will serve as senior advisor during the transition
Historical Context
-
Danaher announced Montgomery’s appointment effective October 1 and Blair’s advisory role through March 31, 2027.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
As previously announced, Rainer Blair will serve as a senior advisor until March 31, 2027 to ensure a seamless transition.
ABOUT DANAHER
Danaher is a leading global life sciences and diagnostics innovator, committed to advancing the power of science and technology to improve human health. Through our connected ecosystem of industry-leading businesses, we work side by side with customers to solve many of their most complex scientific and clinical challenges—accelerating the moment scientific discovery becomes human impact. Powered by the Danaher Business System, our advanced science and technology and proven ability to innovate help enable faster, more accurate diagnoses and reduce the time, cost, and risk required to discover, develop, and deliver life-changing therapies. Through continuous improvement and operational excellence, our approximately 60,000 associates worldwide are focused on delivering lasting impact and improving quality of life around the world, while building a healthier, more sustainable tomorrow. That's Innovation at the speed of life. Explore more at www.danaher.com.
View original content:https://www.prnewswire.com/news-releases/julie-sawyer-montgomery-assumes-role-as-danaher-president-and-chief-executive-officer-302895293.html
SOURCE Danaher Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When did Julie Sawyer Montgomery become Danaher CEO?
Julie Sawyer Montgomery became Danaher's President and Chief Executive Officer on October 1, 2026. She also joined the Board of Directors, as previously announced on August 3, 2026.